Scientifically-backed and Clinically-tested

Unlike other BCI-based technologies, IpsiHand is a non-surgical, non-invasive therapeutic device that is recognized by CMS with a HCPCS code. It leverages contralesional-controlled BCI-therapy to effectively enable recovery for chronic hemiparesis.

The EEG Headset identifies cortical signals from hand regions in the primary cortex of the ipsilateral cerebral hemisphere, sending them to the computer processor to make the handpiece move in real time. With regular use following exercise prompts on their tablet, IpsiHand users show the presence of biomarkers in the brain that demonstrates motor remodeling.

Convenience and Ease of Access

Often, the intensity and task repetitions required for motor improvement isn’t achieved in outpatient therapy alone. That’s why IpsiHand is designed for independent use by patients at home. By improving patient access to home therapy, IpsiHand users can log more therapeutic program hours without direct supervision of an occupational or physical therapist.

The IpsiHand provides patients with improved access to care, minimizes the effects of social determinants of health, and eliminates transportation-related barriers. Ultimately, this therapy increases access to evidence-based care while significantly reducing the costs associated with multiple courses of outpatient therapy, offering a more cost-effective alternative to other neuro-therapeutic technologies.